Skip to main content
Adagene Inc. (ADAG)
NASDAQ: ADAG · Real-Time Price · USD
3.000
+0.160 (5.63%)
At close: Mar 9, 2026, 4:00 PM EDT
3.050
+0.050 (1.67%)
After-hours: Mar 9, 2026, 5:57 PM EDT

Adagene Revenue

Adagene had revenue of $103.20K in the twelve months ending June 30, 2025, down -87.35% year-over-year. In the year 2024, Adagene had annual revenue of $103.20K, down -99.43%.

Revenue (ttm)
$103.20K
Revenue Growth
-87.35%
P/S Ratio
1,351.77
Revenue / Employee
$748
Employees
138
Market Cap
141.39M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024103.20K-18.01M-99.43%
Dec 31, 202318.11M8.82M94.90%
Dec 31, 20229.29M-882.53K-8.67%
Dec 31, 202110.18M9.47M1,351.71%
Dec 31, 2020700.91K220.91K46.02%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MacroGenics 127.63M
Spero Therapeutics 40.55M
Sangamo Therapeutics 32.88M
Oramed Pharmaceuticals 2.00M
Connect Biopharma Holdings 762.00K
Cardiff Oncology 593.00K
Artiva Biotherapeutics 251.00K
Revenue Rankings

ADAG News

More News